Very high-dose streptomycin labyrinthectomy
Sataloff, R.T.; McCarter, A.; Spiegel, J.R.
Ear Nose and Throat Journal 75(4): 239-243
1996
ISSN/ISBN: 0145-5613 PMID: 8935647 Document Number: 456396
Medical labyrinthectomy by systemic administration of streptomycin has proven safe and effective for treatment of selected patients with intractable vertigo. In most patients, 40 grams or less of streptomycin sulfate are required. However, otolaryngologists should be aware that much higher doses can be used safely in selected patients; and a small number of patients may be resistant to streptomycin toxicity even in doses over 100 grams.
Document emailed within 1 workday
Related Documents
Capizzi, R.L.; Powell, B.L. 1987: Sequential high-dose ara-C and asparaginase versus high-dose ara-C alone in the treatment of patients with relapsed and refractory acute leukemias Seminars in Oncology 14(2 Suppl 1: 40-50Arlin, Z.A.; Feldman, E.J.; Finger, L.R.; Ahmed, T.; Mittelman, A.; Cook, P.; Puccio, C.; Baskind, P.; Arnold, P.; Razis, E.D. 1991: Short course high dose mitoxantrone with high dose cytarabine is effective therapy for adult lymphoblastic leukemia Leukemia 5(8): 712-714
Levänen, J.; Nordman, R. 1975: Complete respiratory paralysis caused by a large dose of streptomycin and its treatment with calcium chloride Annals of Clinical Research 7(1): 47-49
Chevallier, B. 1990: Efficacy and safety of granisetron compared with high-dose metoclopramide plus dexamethasone in patients receiving high-dose cisplatin in a single-blind study. the Granisetron Study Group European Journal of Cancer 26(Suppl 1): S33-S36
Knappmann, J.; Gottwald, A. 1973: Animal experiments for testing the diffusion of streptomycin from streptomycin-acrylate cones (Palacos-R) Zeitschrift für Orthopadie und ihre Grenzgebiete 111(1): 62-68
Santini, G.; Coser, P.; Congiu, A.M.; Salvagno, L.; De Souza, C.; Sertoli, M.R.; Olivieri, A.; Chisesi, T.; Rubagotti, A.; Truini, M.; Contu, A.; Porcellini, A.; Zambaldi, G.; Nati, S.; Marino, G.; Rizzoli, V. 2000: VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group Haematologica 85(2): 160-166
Wheeler, R.H.; Ensminger, W.D.; Thrall, J.H.; Anderson, J.L. 1982: High-dose doxorubicin: an exploration of the dose-response curve in human neoplasia Cancer Treatment Reports 66(3): 493-498
Tijssen, J.G. 1998: Low-dose and high-dose acetylsalicylic acid, with and without dipyridamole: a review of clinical trial results Neurology 51(3 Suppl 3): S15-S16
Bhatia, A.; Tripathi, K.D.; Sharma, M. 2003: Comparison of ondansetron with metoclopramide in prevention of acute emesis associated with low dose & high dose cisplatin chemotherapy Indian Journal of Medical Research 118: 33-41
Davis, J.C.; Fessler, B.J.; Tassiulas, I.O.; McInnes, I.B.; Yarboro, C.H.; Pillemer, S.; Wilder, R.; Fleisher, T.A.; Klippel, J.H.; Boumpas, D.T. 1998: High dose versus low dose fludarabine in the treatment of patients with severe refractory rheumatoid arthritis Journal of Rheumatology 25(9): 1694-1704
Capizzi, R.L.; Yang, J.L.; Rathmell, J.P.; White, J.C.; Cheng, E.; Cheng, Y.C.; Kute, T. 1985: Dose-related pharmacologic effects of high-dose ara-C and its self-potentiation Seminars in Oncology 12(2 Suppl 3: 65-74
Hua, X.-m.; Ren, X.-w.; Liu, F.-l.; Liu, Y.; Zhang, C.-j.; Li, Z.-j.; Xu, L.; Liu, J.-y.; Liu, Y.-g. 2004: Comparision of high dose impulsion and low dose density chemotherapeutic regimens with paclitaxel plus cisplatin in advanced NSCLC Zhonghua Zhong Liu Za Zhi 26(10): 621-625
Rattanasupar, A.; Sengmanee, S. 2016: Comparison of High Dose and Standard Dose Proton Pump Inhibitor before Endoscopy in Patients with Non-Portal Hypertension Bleeding Journal of the Medical Association of Thailand 99(9): 988-995
Schneider, W.; Bussmann, W.D.; Stahl, B.; Wietschoreck, A.; Kaltenbach, M. 1985: The antianginal efficacy of isosorbide dinitrate: dose-response relation and long-term effects of high-dose treatment Zeitschrift für Kardiologie 74(Suppl 1): 55-63
Poon, N.; Chaudakshetrin, P.; Sritongkul, N.; Tuntawiroon, M. 2016: Total Effective Dose Equivalent to Caregivers from Hospitalized Patients Treated with High Dose Radioiodine for Thyroid Carcinoma Journal of the Medical Association of Thailand 99(2): 225-230
Armenta, D.; Espallargas, C.; Paz, A.; Rodríguez Martorel, J.; Ladines, R.; Alvarez, C.; Román, J.; Andrés, P. 1996: Complete cytogenetic remission of chronic myeloid leukemia with low-dose interferon alfa-2b and monthly high-dose busulfan Sangre 41(6): 465-467
Fennelly, D.W.; Aghajanian, C.; Shapiro, F.; O'Flaherty, C.; O'Connor, K.; Curtin, J.P.; Crown, J.P.; Hoskins, W.J.; Spriggs, D.R. 1997: Dose escalation of paclitaxel with high-dose carboplatin using peripheral blood progenitor cell support in patients with advanced ovarian cancer Seminars in Oncology 24(1 Suppl 2: S2
Lala, A.; Berger, J.S. 2011: Percutaneous coronary intervention for acute coronary syndromes: no difference in 30-day efficacy or safety of high- and low-dose aspirin; double-dose clopidogrel reduces 30-day risk of cardiovascular death, myocardial infarction or stroke compared with standard dose but increases risk of major bleeding Evidence-Based Medicine 16(3): 80-81
Nakano, K.; Yamamoto, M.; Iwamoto, H.; Hiramoto, T. 2003: Daily low-dose cisplatin plus concurrent high-dose thoracic radiotherapy in elderly patients with locally advanced unresectable non-small-cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(9): 1283-1287
Jonasch, E.; Kumar, U.N.; Linette, G.P.; Hodi, F.S.; Soiffer, R.J.; Ryan, B.F.; Sober, A.J.; Mihm, M.C.; Tsao, H.; Langley, R.G.; Cosimi, B.A.; Gadd, M.A.; Tanabe, K.K.; Souba, W.; Haynes, H.A.; Barnhill, R.; Osteen, R.; Haluska, F.G. 2000: Adjuvant high-dose interferon alfa-2b in patients with high-risk melanoma Cancer Journal 6(3): 139-145